Although big tech continues massive capital expenditures – and the genuine enthusiasm from this month’s Nvidia GTC and RSAC events is still being felt – mainstream enterprises are once again ...
When Goldman Sachs speaks, markets pay attention. On March 26, the $3.6 trillion asset manager published research that should prompt anyone sitting on the sidelines to reconsider their position: the ...
Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue to improve to Week 40, with 62% of patients treated ...
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results